Chronic hypertension screening: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
|||
| Line 37: | Line 37: | ||
|-bgcolor="Beige" | |-bgcolor="Beige" | ||
| Renovascular hypertension | | Renovascular hypertension | ||
|bgcolor="Beige"| Doppler flow study; [[magnetic resonance angiography]] | |bgcolor="Beige"| [[Doppler]] flow study; [[magnetic resonance angiography]] | ||
|- | |- | ||
|-bgcolor="Beige" | |-bgcolor="Beige" | ||
Revision as of 15:42, 4 October 2012
|
Hypertension Main page |
Overview
The Joint National Committee seventh report (JNC 7) defines hypertension as a systolic blood pressure of over 140 mm Hg or a diastolic blood pressure greater than 90 mm Hg based upon the average of two or more properly measured readings at each of two or more visits after an initial screen[1].
Screening test for identifiable Hypertension
| Diagnosis | Diagnostic Tests |
| Chronic kidney disease | Estimate GFR |
| Coarctation of aorta | CT angiography |
| Cushing's syndrome and other glucocorticoid excess states including chronic steroid therapy | History; dexamethasone suppression test |
| Drug induced/related | History; drug screening |
| Pheochromocytoma | 24 hour urinary metanephrine and normetanephrine |
| Primary aldosteronism and other mineralocorticoid 24-hour urinary aldosterone level or excess states | 24-hour urinary aldosterone level or specific measurements of other mineralocorticoids |
| Renovascular hypertension | Doppler flow study; magnetic resonance angiography |
| Sleep apnea | Sleep study with O2 saturation |
| Thyroid/ Parathyroid disease | TSH; serum PTH |
References
- ↑ Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL; et al. (2003). "The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report". JAMA. 289 (19): 2560–72. doi:10.1001/jama.289.19.2560. PMID 12748199.